Pediatric Bipolar disorder: An issue for Child Welfare

Children and Youth Services Review

Volumn 32, Issue 7, 2010, Pages 965-973

  Littrell, Jill ^a   Lyons, Peter ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

Author keywords

Child Welfare; Kindling; Pediatric Bipolar; Psychopharmacology

Indexed keywords

EID: 77952876939     PISSN: 01907409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.childyouth.2010.03.021     Document Type: Article

References (157)

1. Alexander G.E., Crutcher M.D., DeLong M.R. Basal-ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Progress in Brain Research 1990, 85:119-146.
2. Practice parameters for the assessment and treatment of children and adolescents with Bipolar Disorder. Journal of the American Academy of Child and Adolescent Psychiatry 1997, 36(10 Supplement):157S-176S. American Academy of Child and Adolescent Psychiatry.
3. Anand A., Verhoeff P., Seneca N., Zoghbi S.S., Seibyl J.P., Charney D.S., Innis R.B. Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients. American Journal of Psychiatry 2000, 157:1108-1114.
4. Anglada T. Brandon and the bipolar bear: A story for children with bipolar disorder 2004, Trafford Publishing, Victoria, B. C. Canada.
5. Anthony J., Scott P. Manic-depressive psychosis in childhood. Journal of Child Psychology and Psychiatry 1960, 4:53-72.
6. Baethge C., Smolka M.N., Gruschka P., Berghöfer, Schlattmann P., Bauer M., et al. Does prophylaxis-delay in bipolar disorder influence outcome? Results from a long-term study of 147 patients. Acta Psychiatrica Scandanavia 2003, 107:260-267.
7. Baethge C., Tondo L., Bratti I.M., Bschor T., Bauer M., Viguera A.C., Baldessarini R.J. Prophylaxis latency and outcome in bipolar disorders. Canadian Journal of Psychiatry 2003, 48(7):449-457.
8. Baker D.A., McFarland K., Lake R.W., Shen H., Tang X.-C., Toda S., et al. Neuroadaptations in the cystine-glutamate exchange underlie cocaine relapse. Nature Neuroscience 2003, 6(7):743-749.
9. Baldessarini R.J., Tondo L., Baethge C.L., Bratti I.M. Effect of treatment latency on response to maintenance treatment in manic-depressive disorders. Bipolar Disorder 2007, 9:386-393.
10. Baldessarini R.J., Tondo L., Hennen J. Treatment-latency and previous episodes: relationships to pretreatment morbidity and response to maintenance treatment in bipolar I and II disorders. Bipolar Disorders 2003, 5:169-179.
11. Banu S.H., Jahan M., Koli U.K., Ferdousi S., Khan N.Z., Neville B. Side effects of phenobarbital and carbamazepine in childhood epilepsy: Randomized controlled trial. British Medical Journal 2007, 334:1207-1213.
12. Barzman D.H., DelBello M.P., Kowatch R.A., Gernert B., Fleck D.E., Pathak S., et al. The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: A retrospective chart review. Journal of Child and Adolescent Psychopharmacology 2004, 14:593-600.
13. Bearden C.E., Hoffman K.M., Cannon T.D. The neuropsychology and neuroanatomy of bipolar affective disorder: A critical review. Bipolar Disorders 2001, 3:106-150.
14. Bendz H., Aurell M., Lanke J. A historical cohort study of kidney damage in long-term lithium patients: Continued surveillance needed. European Psychiatry 2001, 16:199-206.
15. Biederman J., Faraone S., Mick E., Wozniak J., Chen L., Ouellette C., et al. Attention-deficit hyperactivity disorder and juvenile mania: A overlooked co-morbidity?. Journal of the American Academy of Child and Adolescent Psychiatry 1996, 35:997-1008.
16. Biederman J., Mick E., Faraone S.V., Spencer T., Wilens T.E., Wozniak J. Pediatric mania: A developmental subtype of bipolar disorder?. Biological Psychiatry 2000, 48:458-466.
17. Biederman J., Mick E., Hammerness P., Harpold T., Aleardi M., Dougherty M., et al. Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children. Biological Psychiatry 2005, 58:589-594.
18. Birmaher B., Axelson D., Goldstein B., Strober M., Gill M.K., Hunt J., et al. Four-year longitudinal course of children and adolescent with bipolar spectrum disorders: The course and outcome of bipolar youth (COBY) study. American Journal of Psychiatry 2009, 166:795-804.
19. Blader J.C., Carlson G.A. Increased rates of bipolar disorder diagnoses among U.S. child, adolescent, and adult inpatients, 1996-2004. Biological Psychiatry 2007, 62(2):107-114.
20. Borchers A.T., Lee J.L., Naguwa S.M., Cheema G.S., Gershwin M.E. Stevens-Johnson syndrome and toxic epidermal necrolysis. Autoimmune Review 2008, 7(8):598-605.
21. Boylan L.S., Devinsky O., Barry J.J., Ketter T.A. Psychiatric uses of antiepileptic treatments. Epilepsy & Behavior 2002, 3(Suppl. 5):54-59.
22. Brown L.L., Schneider J.S., Lidsky T.I. Sensory and cognitive functions of the basal ganglia. Current Opinion in Neurobiology 1997, 7:157-163.
23. Burns B.J., Phillips S.D., Wagner H.R., Barth R., Kolko D.J., Campbell Y., et al. Mental health need and access to mental health services by youths involved with child welfare: A national survey. Journal of the American Academy of Child and Adolescent Psychology 2004, 43:960-970.
24. Carlson G. Child and adolescent mania: Diagnostic considerations. Journal of Child Psychology and Psychiatry 1990, 31:331-341.
25. Casey D.E. Implications of the CATIE trial on treatment: Extrapyramidal symptoms. CNS Spectrum 2006, 11(Suppl. 7):25-31.
26. Castino R., Lazzeri G., Lenzi P., Bellio N., Follo C., Ferrucci M., et al. Suppression of autophagy precipitates neuronal cell death following low doses of methamphetamine. Journal of Neurochemistry 2008, 106:1426-1439.
27. Cecil K.M., DelBello M.P., Morey R., Strakowski S.M. Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy. Bipolar Disorders 2002, 4(6):357-365.
28. Chen P.S. Valporate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. Molecular Psychiatry 2006, 11:1116-1125.
29. Chromy S. Sexually abused children who exhibit sexual behavior problems: Victimization characteristics. Brief Treatment and Crisis Intervention 2007, 7(7):25-33.
30. Cicero D., El-Mallakh R.S., Holman J., Robertson J. Antidepressant exposure in bipolar children. Psychiatry 2003, 66(4):317-322.
31. Cicero D., Epler A.J., Sher K.J. Are there developmentally limited forms of bipolar disorder?. Journal of Abnormal Psychology 2009, 118:431-447.
32. Clausen J.M., Landsverk J., Ganger W., Chadwick D., Litrownik A. Mental health problems of children in foster care. Journal of Child & Family Studies 1998, 7:283-296.
33. Cooper W.O., Hickson G.B., Fuchs C., Arbogast P.G., Ray W.A. New users of antipsychotic medications among children enrolled in TennCare. Archives of Pediatric and Adolescent Medicine 2004, 158:753-759.
34. Correll C.U., Carlson H.E. Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 2006, 45:771-791.
35. Courtney M.E., Piliavin I., Grogan-Kaylor A. The Wisconsin study of youth aging out of out-of-home care: A portrait of children about to leave care 1995, WI7 Institute of Poverty Research, Madison.
36. Crimson M.L., Argo T. The use of psychotropic medication for children in foster care. Child Welfare 2009, 88(1):72-100.
37. Crystal S., Olfson M., Huang C., Pincus, Gerhard T. Broadened use of atypical antipsychotics: Safety, effectiveness, and policy challenges. Health Affairs 2009, 28(5):770-781.
38. Danner S., Fristad M.A., Arnold E., Youngstrom E.A., Birmaher B., Horwitz S.M., et al. Early-onset bipolar spectrum disorders: Diagnostic issues. Clinical Child and Family Psychological Review 2009, 12:271-293.
39. DelBello M.P., Cecil K.M., Adler C.M., Daniels J.P., Strakowski S.M. Neurochemical effects of olanzapine in first-hospitalization manic adolescents: A proton magnetic resonance spectroscopy study. Neuropsychopharmacology 2006, 31:1264-1273.
40. DelBello M.P., Soutullo C.A., Hendricks W., Niemeier R.T., McElroy S.L., Strakowski S.M. Prior stimulant treatment in adolescents with bipolar disorder: Association with age at onset. Bipolar Disorders 2001, 3:53-57.
41. DeLong M., Wichmann T. Circuits and circuit disorders of the basal ganglia. Archives of Neurology 2007, 64(1):20-24.
42. Dickstein D.P., Towbin K.E., Van Der Veen J.W., Rich B.A., Brotman M.A., Knopf L., et al. Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation. Journal of Child and Adolescent Psychopharmacology 2009, 19(1):61-73.
43. dosReis S., Zito J.M., Safer D.J., Soeken K.L. Mental health services for youths in foster care and disabled youths. American Journal of Public Health 2001, 91:1094-1099.
44. Drevets W.C. Neuroimaging studies of mood disorders. Biological Psychiatry 2000, 48:813-828.
45. Duffy A., Alda M., Hajek T., Grof P. Early course of bipolar disorder in high-risk offspring: Prospective study. British Journal of Psychiatry 2009, 195:457-458.
46. Faedda G.L., Baldessarini R.J., Glovinsky I.P., Austin N.B. Treatment-emergent mania in pediatric bipolar disorder: A retrospective case review. Journal of Affective Disorders 2004, 82:149-158.
47. Fanshel D., Finch S.J., Grundy J.F. Foster children in a life course perspective 1990, NY Columbia University Press, New York.
48. FDA Alert. (12/12/2007). Information on carbamazine. Available at: Retrieved 9/21/08. http://www.fda.gov/cder/drug/infopage/carbamazine/default.htm.
49. Feeny N.C., Danielson C.K., Schwartz L., Youngstrom E.A., Findling R.L. Cognitive-behavioral therapy for bipolar disorders in adolescents: A pilot study. Bipolar Disorders 2006, 8(5):508-515.
50. Ferguson D.G., Glesener D.C., Raschick M. Psychotropic drug use with European American and American Indian children in foster care. Journal of Child and Adolescent Psychopharmacology 2006, 16:474-481.
51. Fountoulakis K.N. The contemporary face of bipolar illness: Complex diagnostic and therapeutic challenges. CNS Spectrums 2008, 13(9):763-774. 777-779.
52. Frangou S., Donaldson S., Hadjulis M., Landau S., Goldstein L.H. The Maudsley Bipolar Disorder Project: Executive dysfunction in bipolar disorder I and its clinical correlates. Biological Psychiatry 2005, 58:859-864.
53. Garland A.F., Landsverk J.A., Hough R.L., Ellis-MacLeod E. Type of maltreatment as a predictor of mental health service use in foster care. Child Abuse and Neglect 1996, 20:675-688.
54. Geller B., Fox L.W., Clark K.A. Rate and predictors of prepubertal bipolarity during follow-up of 6- and 12-year-old depressed children. Journal of the American Academy of Child and Adolescent Psychiatry 1994, 33(4):461-468.
55. Geller B., Sun K., Zimerman B., Luby J., Frazier J., Williams M. Complex and rapid-cycling in bipolar children and adolescents: A preliminary study. Journal of Affective Disorders 1995, 34:259-268.
56. Geller B., Tillman, Bolhofner K., Zimerman B. Child bipolar disorder: Prospective continuity with adult bipolar I disorder; characteristics of second and third episodes; predictors of 8-year outcome. Archives of General Psychiatry 2008, 65(10):1125-1133.
57. Ghaemi S.N. Practical guides in psychiatry: Mood disorders 2008, Lippincott, Williams, & Wilkins, New York. 2nd ed.
58. Ghaemi S.N., Hsu D.J., Soldani F., Goodwin F.K. Antidepressants in bipolar disorder: The case for caution. Bipolar Disorders 2003, 5:421-433.
59. Ghaemi S.N., Ko J.Y. Polypharmacy of bipolar disorder. Polypharmacy in psychiatry 2002, 35-77. Marcel Dekker, Inc, New York. S.N. Ghaemi (Ed.).
60. Ghaemi S.N., Ko J.Y., Goodwin F. "Cade's disease" and beyond: Misdiagnosis, antidepressant use, and a proposed definition of bipolar spectrum disorder. Canadian Journal of Psychiatry 2002, 47(2):125-134.
61. Ghaemi S.N., Martin A. Defining the boundaries of childhood bipolar disorder. American Journal of Psychiatry 2007, 162(2):185-188.
62. Gleason M.M., Egger H.L., Emslie G.J., Greenhill L.L., Kowatch R.A., Lieberman A.F., et al. Psychopharmacological treatment for very young children: Context and guidelines. Journal of the American Academy of Child and Adolescent Psychiatry 2007, 46:1532-1572.
63. Glisson C. Judicial and service decisions for children entering state custody: The limited role of mental health. Social Service Review 1996, 70:257-281.
64. Glovinsky I. A brief history of childhood-onset bipolar disorder through 1980. Child and Adolescent Psychiatric Clinics of North America 2002, 11:443-460.
65. Goodwin F.M. Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder. British Journal of Psychiatry 1994, 64:149-152.
66. Goodwin F.K., Jamison K.R. Manic-depressive illness: Bipolar disorders and recurrent depression 2007, Oxford Press, New York. 2nd ed.
67. Green J., McDonald W.M., Vitek J.L., Evatt M., Haber M., Bakay R.A., et al. Cognitive impairments in advanced PD without dementia. Neurology 2002, 59(12):1320-1340.
68. Grunze H.C.R. Switching, induction of rapid cycling, and increased suicidality with antidepressants in bipolar patients: Fact or overinterpretation?. CNS Spectrums 2008, 13(9):790-795.
69. Hagino O.R., Weller E.B., Weller R.A., Washing D., Fristad M.A., Kontras S.B. Untoward effects of lithium treatment in children aged four through six years. Journal of the American Academy of Child and Adolescent Psychiatry 1995, 34:1584-1590.
70. Halfon N., Berkowiz G., Klee L. Children in foster care in California: An examination of Medicaid reimbursed health services utilization. Pediatrics 1992, 89:1230-1237.
71. Halfon N., Berkowiz G., Klee L. Mental health service utilization by children in foster care in California. Pediatrics 1992, 89:1238-1244.
72. Halfon N., Mendonca A., Berkowitz G. Health status of children in foster care: The experience of the Center for the Vulnerable Child. Archives of Pediatrics & Adolescent Medicine 1995, 149:386-392.
73. Harman J.S., Childs G.E., Kelleher K.J. Mental health care utilization and expenditures by children in foster care. Archives of Pediatrics & Adolescent Medicine 2000, 154:1114-1117.
74. Harris J. The increased diagnosis of "juvenile bipolar disorder": What are we treating?. Psychiatric Services 2005, 56:529-531.
75. Harris, G. and Carey, B. (2008a, June 8). Researchers fail to reveal full drug pay: Possible conflicts seen in Child Psychiatry, New York Times. Retrieved October 3, 2008, from http://www.nytimes.com.
76. Harris, G., and Carey, B. (2008b, July 12). Psychiatric Association faces Senate scrutiny over drug industry ties. New York Times, A 13.
77. Healy D. The latest mania: Seeing disease mongering everywhere [electronic version]. PloS Medicine 2006, 3(4):185.
78. Healy D. Mania: A short history of bipolar disorder 2008, John Hopkins University Press, Baltimore, MD.
79. Hollander E. New insights into bipolar disorder. CNS Spectrums 2008, 13(9):743.
80. Hong S.H., Shepherd M.D. Psychosocial and demographic predictors of pediatric psychotropic medication use. American Journal of Health-System Pharmacy 1996, 53:1934-1939.
81. Howland R.D., Mycek M.J. Pharmacology 2006, Lippincott, Williams, & Wilkins, New York. 3rd ed.
82. Hulsey T.C., White R. Family characteristics and measures of behavior in foster and nonfoster children. American Journal of Orthopsychiatry 1989, 59(4):502-509.
83. Isaac G. Is bipolar disorder the most common diagnostic entity in hospitalized adolescents and children?. Adolescence 1995, 30:273-276.
84. Isojarvi J.I.T., Laatikainen T.J., Pakarienen A.J., Juntunen K.T.S., Myllyla V.V. Polycystic ovaries and hyperandrogenism in women taking valporate for epilepsy. New England Journal of Medicine 1993, 329:1383-1388.
85. Janeway C.A., Travers P., Walport M. Immunobiology: The immune system in health and disease 2008, Garland Science, New York. 7th ed.
86. Kalivas P.W. The glutamate homeostasis hypothesis of addiction. Nature Reviews: Neuroscience 2009, 10:561-572.
87. Kalivas P.W., Peters J., Knackstedt L. Animal models and brain circuits in drug addiction. Molecular Interventions 2006, 6(6):339-344.
88. Kravtochvil C.J., Greenhill L., Swanson J. The role of stimulants in the treatment of preschool children with attention-deficit hyperactivity disorder. CNS Drugs 2006, 18:957-967.
89. Kuehn B.M. FDA panel OKs 3 antipsychotic drugs for pediatric use, cautions against overuse. Journal of the American Medical Assocation 2009, 302(8):833-834.
90. Landsverk J., Garland A.F., Leslie L.K. Mental health services for children reported to Child Protective Services. APSAC Handbook on Child Maltreatment 2002, 487-507. Sage Publications, Thousand Oaks, California. J.E.B. Myers, L. Berliner, J. Briere, C.T. Hendrix, C. Jenny, T.A. Reid (Eds.).
91. Lazzeri G., Lenzi P., Busceti C.L., Ferrucci M., Falleni A., Bruno V., et al. Mechanisms involved in the formation of dopamine-induced intracellular bodies within striatal neurons. Journal of Neurochemistry 2007, 101:1414-1427.
92. Leslie L., Kelleher K., Burns B., Landsverk J., Rolls J. Foster care and Medicaid managed care. Child Welfare League of America 2003, 82(3):367-392.
93. Lewinsohn P.M., Klein D.N., Seeley J.R. Bipolar disorder during adolescence and young adulthood in a community sample. Bipolar Disorders 1995, 2:281-293.
94. Littrell J., Lyons P. Pediatric bipolar disorder: Part I-Is it related to classical bipolar?. Children and Youth Services Review 2010.
95. Loranger A., Levine P. Age at onset of bipolar affective illness. Archives of General Psychiatry 1978, 35:1345-1348.
96. Loring D.W., Meador K.J. Cognitive side effects of antiepileptic drugs in children. Neurology 2004, 62:872-877.
97. Luby J., Stalets M., Belden A. Psychotropic prescriptions in a sample of healthy and mood disruptive disordered preschoolers: Relationships to diagnosis, impairment, prescriber type, and assessment methods. Journal of Child and Adolescent Psychopharmacology 2007, 17:205-215.
98. Manji H.K., Moore G.J., Chen G. Clinical and preclinical evidence for neurotrophic effects of mood stabilizers: Implications for the pathophysiology and treatment of manic-depressive illness. Biological Psychiatry 2000, 48:740-754.
99. Manschreck T.C., Boshes R.A. The CATIE schizophrenia trial: results, impact, controversy. Harvard Review of Psychiatry 2007, 15(5):245-258.
100. Markowitz G.S., Radhakrishnan J., Kambham N., Valeri A.M., Hines W.H., D'Agati V.D. Lithium nephrotoxicity: A progressive combined glomerular and tubulointerstitial nephropathy. Journal of the American Society of Nephrology 2000, 11:1439-1448.
101. Marson A., Jacob A., Johnson A., Kim L., Gamble C., Chadwick D. Immediate versus deferred antiepileptic drug treatment for epilepsy and single seizures: A randomized controlled trial. Lancet 2005, 365:2007-2013.
102. Martin A., Young C., Leckman J.F., Mukonoweschuro C., Rosenheck R., Leslie D. Age effects on antidepressant-induced manic conversion. Archives of Pediatric Adolescent Medicine 2004, 158(8):773-780.
103. Meyer S.E., Carlson G.A., Wiggs E.A., Martinez P.E., Ronsaville D.S., Klimes-Dougan B., et al. A prospective study of the association among impaired executive functioning, childhood attentional problems, and the development of bipolar disorder. Development and Psychopathology 2004, 14:461-476.
104. Miklowitz D.J., Axelson D.A., Birmaher B., George E.L., Taylor D.O., Schneck C.D., et al. Family-focused treatment for adolescents with bipolar disorder: Results of a 2-year randomized trial. Archives of General Psychiatry 2008, 65(9):1053-1061.
105. Miller D.D., EcVoy J.P., Davis S.M., Caroff S.N., Saltz B.L., Chakos M.H., et al. Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial. Schizophrenia Research 2005, 80(1):33-43.
106. Moore G.J., Bechuck J.M., Hasanat K., Chen G., Seraji-Bozorgzad N., Wilds I.B. Lithium increases N-acetyl-aspartate in human brain: In vivo evidence in support of bcl-2′s neurotrophic effects. Biological Psychiatry 2000, 48:1-8.
107. Moreno C., Laje G., Blanco C., Jiang H., Schmidt A.B., Olfson M. National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Archives of General Psychiatry 2007, 64(9):1032-1039.
108. Musicco M., Beghi E., Solari A., Viani F. Treatment of first tonic-clonic seizure does not improve the prognosis of epilepsy. Neurology 1997, 49:991-998.
109. Myslobodsky M.S. Central determinants of attention and mood disorder in tardive dyskinesia ("tardive dysementia"). Brain and Cognition 1993, 23:88-101.
110. Nandagopal J., DelBello M.P., Kowatch R. Pharmacologic treatment of pediatric bipolar disorder. Child and Adolescent Psychiatric Clinics of North America 2009, 18(2):455-469.
111. National Institute of Mental Health Research Roundtable on prepubertal bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2001, 40:871-878. National Institute of Mental Health.
112. Oepen G., Baldessarini R.J., Salvatore P. On the periodicity of manic-depressive insanity by Eliot Slater (1938): Translated excerpts and commentary. Journal of Affective Disorders 2004, 78(1):1-9.
113. Olfson M., Blanco C., Liu L., Moreno C., Laje G. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Archives of General Psychiatry 2006, 63:679-685.
114. Papolos D.M., Papolos J. The bipolar child 2006, Broadway Books, New York. 3rd ed.
115. Patel N.C., Crismon M.L., Hoagwood K., Johnsrud M.T., Rascati K.L., Wilson J.P., et al. Trends in the use of typical and atypical antipsychotics in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 2005, 44(6):548-556.
116. Pavuluri M.N., Birmaher B., Naylor M.W. Pediatric bipolar disorder: A review of the past 10years. Journal of the American Academy of Child and Adolescent Psychiatry 2005, 44(9):846-871.
117. Pilowsky D. Psychopathology among children placed in family foster care. Psychiatric Services 1995, 46:906-910.
118. Post R.M. Neurobiology of seizures and behavioral abnormalities. Epilepsia 2004, 45(Suppl. 2):5-14.
119. Post R.M. Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena. Neuroscience and Biobehavioral Reviews 2007, 31:858-873.
120. Post R.M., Luckenbaugh D.A., Leverisch G.S., Altshuler L.L., Frye M.A., Suppes T., et al. Incidence of childhood-onset bipolar illness in the USA and Europe. British Journal of Psychiatry 2008, 192:150-152.
121. Postma T., Krupp E., Li X.L., Post R.M., Weiss S.R. Lamotrigine treatment during amygdala-kindled seizure development fails to inhibit seizures and diminishes subsequent anticonvulsant efficacy. Epilepsia 2000, 41(12):1514-1521.
122. Presne C., Fakhouri F., Noiol L.-H., Stengel B., Even C., Kreis H., et al. Lithium-induced nephropathy: Rate of progression and prognostic factors. Kidney International 2003, 64:585-592.
123. Raghavan, R., and McMillen, J. C. (2007, March). Patterns of psychotropic medication use among older adolescents in foster care. Paper presented at the Academy Health Annual Research Meeting, Orlando, FL.
124. Raghavan R., McMillen J.C. Use of multiple psychotropic medications among adolescents aging out of foster care. Psychiatric Services 2008, 59(9):1052-1055.
125. Raghavan R., Zima B.T., Andersen R.M., Leibowitz A.A., Schuster M.A., Landsverk J. Psychotropic medication use in a national probability sample of children in the child welfare system. Journal of Child and Adolescent Psychopharmacology 2005, 15:97-106.
126. Ratzoni G., Gothelf D., Brand-Gothelf A., Reidman J., Kikinzon L., Gal G., et al. Weight gain associated with olanzapine and risperidone in adolescent patients: A comparative prospective study. Journal of the American Academy of Child and Adolescent Psychiatry 2002, 41(3):337-343.
127. Redden L., DelBello M., Wagner K.D., Wilens T.E., Malhotra S., Wozniak P., et al. Long-term safety of divalproex sodium extended-release in children and adolescent with bipolar I disorder. Journal of Child and Adolescent Psychopharmacology 2009, 19(1):83-89.
128. Safer D.J. A comparison of risperidone-induced weight gain across the life span. Journal of Clinical Psychopharmacology 2004, 24:429-436.
129. Sikich L., Hamer R.M., Bashford R.A., Sheitman B.B., Lieberman J.A. A pilot study of risperidone, olanzapine and haloperidol in psychotic youth: A double-blind, randomized, 8-week trial. Neuropsychopharmacology 2004, 29:133-145.
130. Silva R.R., Campbell M., Golden R.R., Small A.M., Pataki C.S., Rosenberg C.R. Side effects associated with lithium and placebo administration in aggressive children. Psychopharmacology Bulletin 1992, 28:319-326.
131. Simms M.D., Dubowitz H., Szilagyi M.A. Health care needs of children in the foster care system. Pediatrics 2000, 106:909-918.
132. Soutullo C.A., Change K.D., Díaz-Suárez, Figueroa-Quintana A., Escamilla-Canales I., Rapado-Castro M., et al. Bipolar disorder in children and adolescents: International perspective on epidemiology and phenomenology. Bipolar Disorders 2005, 7:497-506.
133. Spetie L., Arnold L.E. Ethical issues in child psychopharmacology research and practice: Emphasis on preschoolers. Psychopharmacology 2007, 191:15-26.
134. Stahmer A.C., Leslie L.K., Hurlburt M.S., Barth R., Webb M.B., Landsverk J.A., et al. Developmental and behavioral needs and service use for young children in child welfare. Pediatrics 2005, 116:891-900.
135. Stein B.D., Sturm R., Kapur K., Ringel J. Psychotropic medication costs among youth with private insurance in 1998. Psychiatric Services 2001, 52:152.
136. Stiffman R.A., Chen Y., Elze D., Dore P., Cheng L. Adolescents' and providers' perspectives on the need for and use of mental health services. Journal of Adolescent Health 1997, 21:335-342.
137. Takayama J.I., Bergman A.B., Connel F.A. Children in foster care in the state of Washington: Health care utilization and expenditures. Journal of the American Medical Association 1994, 271:1850-1855.
138. Temkin N.R. Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: A meta-analysis of controlled trials. Epilepsia 2001, 42(4):515-524.
139. Thompson A.H., Fuhr D. Emotional disturbance in fifty children in the care of a child welfare system. Journal of Social Science Research 1992, 15(3/4):95-112.
140. Tohen M., Kryzhanovskaya L., Carlson G., DelBello M., Wozniak J., Kowatch R., et al. Olanzapine versus placebo in the treatment of adolescents with bipolar mania. American Journal of Psychiatry 2007, 164:1547-1556.
141. Tyre, P. (2004, December). Battling the effects of war. Newsweek. Retrieved September 14, 2008, from http://www.newsweek.com/id/5598.
142. United States Department of Health and Human Services (2006). The Adoption and foster care analysis and reporting system (AFCARS). Retrieved September 24, 2008, from http://www.acf.hhs.gov/programs/cb/stats_research/afcars/tar/report13.htm.
143. U.S. Department of Health and Human Services (2007). The AFCARS Report. Retrieved on September 12, 2008, from http://www.acf.dhhs.gov/programs/cb/stats_research/afcars/tar/report13.htm.
144. Vitiello B. Pediatric psychopharmacology and the interaction between drugs and the developing brain. Canadian Journal of Psychiatry 1998, 43:582-584.
145. Vitiello B. Pharmacoepidemiology and pediatric psychopharmacology research. Journal of Child and Adolescent Psychopharmacology 2005, 15:10-11.
146. Vitiello B. Research in child and adolescent psychopharmacology: Recent accomplishments and new challenges. Psychopharmacology 2007, 191:5-13.
147. Volkow N.D., Fowler J.S., Wang G.J. The addicted brain viewed in the light of imaging studies: Brain circuits and treatment strategies. Neuropharmacology 2004, 47(Suppl. 1):3-13.
148. Volkow N.D., Fowler J.S., Wang G.J., Swanson J.M., Telang F. Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Archives of Neurology 2007, 64(11):1575-1579.
149. Weiss S.R.B., Clark M., Rosen J.B., Smith M.A., Post R.M. Contingent tolerance to the anticonvulsant effects of carbamazepine: Relationship to loss of endogenous adaptive mechanisms. Brain Research Reviews 1995, 20:305-325.
150. Werry J.S., McClellan J.M., Chard L. Childhood and adolescent schizophrenic, bipolar and schizoaffective disorders: A clinical and outcome study. Journal of the American Academy of Child and Adolescent Psychiatry 1991, 30:457-465.
151. Wilson I.C., Garbutt J.C., Lanier C.F., Moylan J., Nelson W., Prange A.J. Is there a tardive dysmentia?. Schizophrenia Bulletin 1983, 9(2):187-192.
152. Woods S.W., Martin A., Spector S.G., McGlashan T.H. Effects of development on olanzapine-associated adverse events. Journal of the American Academy of Child and Adolescent Psychiatry 2002, 41(12):1439-1446.
153. Youngstrom E. Bipolar disorder in children and adolescents 2009, August 28, Symposium Episteme, Ventures, Inc, Atlanta, GA.
154. Zima B.T., Bussing R., Crecelius G.M., Kaufman A., Belin T.R. Psychotropic medication use among children in foster care: Relationship to severe psychiatric disorders. American Journal of Public Health 1999, 89:1732-1735.
155. Zima B.T., Bussing R., Crecelius G.M., Kaufman A., Belin T.R. Psychotropic medication treatment patterns among school-aged children in foster care. Journal of Child & Adolescent Psychopharmacology 1999, 9:135-147.
156. Zima B.T., Bussing R., Yang X., Belin T.R. Help-seeking steps and service use for children in foster care. Journal of Behavioral Health Services and Research 2000, 27(3):271-285.
157. Zito J.M., Safer D.J., Valuri S., Gardner J.F., Korelitz J.J., Mattison D.R. Psychotherapeutic medicine prevalence in Medicaid-insured preschoolers. Journal of the American Academy of Child and Adolescent Psychopharmacology 2007, 17:195-203.